Follow
Therapeutics
Therapeutics: In medicine, the branch that deals specifically with the treatment of disease and the art and science of healing. Exercise, diet, and mental factors are therefore integral to the prevention, as well as the management, of disease processes. More specific measures that are employed to treat specific symptoms include the use of drugs to relieve pain or treat infection, surgery to remove diseased tissue or replace poorly functioning or nonfunctioning organs with fully operating ones, and counseling or psychotherapy to relieve emotional distress.
![[Webinar] Mass Spec Enables More Definitive Biologics Drug Discovery and Optimization](https://d3bkbkx82g74b8.cloudfront.net/eyJidWNrZXQiOiJsYWJyb290cy1pbWFnZXMiLCJrZXkiOiJzcGVha2VyX3Byb2ZpbGVfaW1hZ2VfMWIyM2Y3ODUyOGZmZjUwZjBjY2FlOTkwZWRmYThjODM2ZmFlYjA5M18zMjEwLmpwZyIsImVkaXRzIjp7InRvRm9ybWF0IjoianBnIiwicmVzaXplIjp7IndpZHRoIjoxNTAsImhlaWdodCI6MTUwLCJmaXQiOiJjb3ZlciIsInBvc2l0aW9uIjoiY2VudGVyIiwiYmFja2dyb3VuZCI6IiNmZmYifSwiZmxhdHRlbiI6eyJiYWNrZ3JvdW5kIjoiI2ZmZiJ9fX0=)
OCT 29, 2025 7:00 AM PT
This presentation explores the scientific rationale, preclinical validation, and early clinical translation of STAR-LLD—a novel, continuous low-dose percutaneous lenalidomide delivery...
OCT 01, 2025 | 12:00 PM
The next leap in oncology therapeutics demands speed, precision, and rapid molecular innovation — and AI-driven antibody design (AIDD) is beginning to deliver. In this talk, we will un...
OCT 01, 2025 | 9:00 AM
Our experience collaborating with oncology and immunology leaders in the pharmaceutical and biotech space has revealed the numerous challenges in every stage of drug development. From target...
JUL 10, 2025 | 11:00 AM
Antibody engineering enables the generation of novel and diverse antibody constructs. The development of therapeutic antibodies is highly dependent on antibody engineering, whether for the g...
JUN 25, 2025 | 8:00 AM
Traumatic brain injury, together with adjacent brain conditions such as Alzheimer’s disease, is a global health crisis. In this presentation, Aleksandra Hemm, Product Manager from Ther...
JUN 11, 2025 | 10:00 AM
In advanced therapy development, blood samples are essential to gain molecular insights. RNA and biomarker profiles are highly sensitive to preanalytical variables—such as collection,...
JUN 10, 2025 | 8:00 AM
Bispecific antibodies (bsAbs) represent a versatile and increasingly important class of targeted therapeutics, designed to bind two distinct sites — either two different epitopes on th...
APR 23, 2025 | 9:00 AM
This podcast delves into the innovative role of Dynabeads magnetic beads for mRNA synthesis and purification in the personalized mRNA therapeutic field. It introduces the concept of using Dy...
APR 16, 2025 | 9:00 AM
BrainXell offers the most comprehensive portfolio of high-purity iPSC-derived human neurons and glia, sourced from control, edited and disease lines, to advance translational research and dr...
MAR 25, 2025 | 8:00 AM
Analytical ultracentrifugation is an established method during the development of therapeutic proteins and antibodies and contributes supporting information regarding the size, oligomerizati...
MAR 05, 2025 | 8:00 AM
Antibody-drug conjugates (ADCs) are a novel class of cancer therapeutics comprised of a linker-payload conjugated to a selective monoclonal antibody targeting a tumor-associated antigen (TAA...
JAN 30, 2025 | 1:00 PM
In this webinar, Dr. Clarissa Yates, CEO of Ketim Therapeutics, will share her exciting results from a proteomics pilot study exploring biomarkers associated with postpartum depression (PPD)...
NOV 19, 2024 | 8:00 AM
Cimeio Therapeutics is an applied gene editing and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs™ (SCIP). Gene editing is used to introduce single nucle...
OCT 23, 2024 | 10:30 AM
C.E. CREDITS
CRISPR has emerged as a promising alternative to viral-based gene editing by allowing scientists to modify genes with unprecedented ease and flexibility. The discovery and development of a d...
OCT 23, 2024 | 7:30 AM
C.E. CREDITS
This talk will provide an overview of our work in the design of self-assembled, functionalised peptide and protein nanoparticles, hydrogels and bio-interfaces for applications in healthcare....
On Demand
C.E. CREDITS
Gene therapy has experienced an increasing number of successful human clinical trials, leading to 6 FDA approved products using delivery vectors based on adeno-associated viruses (AAV). Thes...
OCT 16, 2024 | 10:30 AM
C.E. CREDITS
The use of biologic-based therapeutics has revolutionized our ability to treat complex diseases such as cancer- and autoimmune-related disorders. Biologic-based therapeutics are known to gen...
OCT 16, 2024 | 7:30 AM
C.E. CREDITS
Across the entire spectrum of the life sciences sector, from academia and hospitals to pharmaceutical and biotech companies, enormous amounts of resources are invested in the development of...
OCT 01, 2024 | 7:00 AM
The human antibody repertoire, or reactome, is a vast and dynamic network of antibody-antigen interactions that plays a crucial role in health and disease. Understanding the complexity of th...
SEP 18, 2024 | 9:00 AM
C.E. CREDITS
The disposition of antibody-based therapeutics is generally determined by both target-mediated and non-target processes, the latter being an often-overlooked aspect. Target-independent liabi...